Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_assertion type Assertion NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_head.
- NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_assertion description "[Because no data are available on the involvement of the plasmin activation system in matrix degradation by thyroid carcinoma, the present study was performed using follicular thyroid carcinoma cell lines obtained from a primary tumor (FTC-133) and metastases (FTC-236 and FTC-238) of one patient.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_provenance.
- NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_assertion evidence source_evidence_literature NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_provenance.
- NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_assertion SIO_000772 10524570 NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_provenance.
- NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_assertion wasDerivedFrom befree-20150227 NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_provenance.
- NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_assertion wasGeneratedBy ECO_0000203 NP630676.RARx3d6K2UjVdxLxeZOEn2e9DHtHSnYWks6VS0Xus7o_M130_provenance.